BRISBANE, Calif., June 04, 2024 (GLOBE NEWSWIRE) Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of.
BRISBANE, Calif., June 04, 2024 Annexon, Inc. , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical.
Annexon Announces Proposed Public Offering of Common Stock tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Call scheduled for Tuesday, June 4, 2024 at 8:30 a.m. ETBRISBANE, Calif., June 03, 2024 Annexon, Inc. , a clinical-stage biopharmaceutical company developing a new class of complement-based.
Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.